Doctor profile · Federal record
Dr. DANIEL MARRERO, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · BAYSIDE, NY
- NPI 1245487081
- Accepts Medicare
- MIPS 84.5 / 100 · 2023
- 21 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4401 FRANCIS LEWIS BLVD, SUITE L3A
BAYSIDE, NY 113613028
(718) 423-3355
fax (718) 423-3721
Credentials & registration
- NPI registered
- August 2008 — 18 yrs on file
- Profile last updated
- February 23, 2021
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- New York #249606
- Medicaid
- NY #03463054
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1245487081. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,895
Distinct HCPCS
10
Medicare allowed
$371,929
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 659 | 381 | $148 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 657 | 420 | $17 | |
J2785 |
Injection, regadenoson, 0.1 mg | 276 | 69 | $56 | |
93880 |
Ultrasound of both sides of head and neck blood flow | 231 | 231 | $231 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 210 | 104 | $121 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 176 | 175 | $229 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 155 | 152 | $74 | |
78452 |
Nuclear medicine studies of heart muscle at rest and with stress and spect | 105 | 104 | $531 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 102 | 102 | $196 | |
36415 |
Insertion of needle into vein for collection of blood sample | 46 | 39 | $8 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 186. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$164
Transactions
3
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boston Scientific Corporation | 2 | $146.45 | |
| HEARTFLOW, INC. | 1 | $17.27 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,038
Patients
951
Total drug cost
$917,526
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 414 | 115 | $502,771 |
| Amlodipine Besylate | Generic | 383 | 138 | $3,497 |
| Metoprolol Succinate | Generic | 371 | 113 | $8,266 |
| Atorvastatin Calcium | Generic | 364 | 114 | $5,620 |
| Carvedilol | Generic | 314 | 90 | $3,197 |
| Entresto (Sacubitril/Valsartan) | Brand | 155 | 43 | $222,445 |
| Rosuvastatin Calcium | Generic | 151 | 54 | $4,186 |
| Valsartan-Hydrochlorothiazide (Valsartan/Hydrochlorothiazide) | Brand | 149 | 47 | $10,482 |
| Losartan Potassium | Generic | 137 | 49 | $2,021 |
| Valsartan | Generic | 116 | 37 | $4,751 |